Understanding the Molecular Landscape of Alopecia Areata: Key Genes, Regulatory Networks, and Therapeutic Targets

June 2026 in “ Health Science Reports ”

Ahmed Ibrahim AbdElneam, Mohammed Saleh Al‐Dhubaibi, Saleh Salem Bahaj, Ghada Farouk Mohammed, Lina Mohammed Atef

TLDR Key genes and pathways in alopecia areata were identified, suggesting new treatment targets.

This study on alopecia areata (AA) used bioinformatics to analyze genetic data from the GEO database, identifying 5134 differentially expressed genes (DEGs) between healthy individuals and AA patients. Key findings include the identification of 10 hub genes, such as CCL5 and CXCL9, and top transcription factors like ZNF683, which are involved in chemokine signaling and cytokine-cytokine receptor interactions. Additionally, 49 miRNAs were predicted to regulate genes related to AA. These insights into the molecular landscape of AA highlight potential therapeutic targets and enhance understanding of its pathogenesis.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

18 / 18 results

research Regulatory T Cells in Skin Mediate Immune Privilege of the Hair Follicle Stem Cell Niche

21 citations , January 2024 in “Science Immunology”

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

research Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata

16 citations , January 2022 in “International journal of molecular sciences”

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

research Perspectives on MicroRNAs Targeting DKK1 for Developing Hair Regeneration Therapy

12 citations , October 2021 in “Cells”

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

research Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management

290 citations , August 2021 in “Clinical Reviews in Allergy & Immunology”

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

research Current Insight Into the Functions of MicroRNAs in Common Human Hair Loss Disorders: A Mini Review

22 citations , April 2021 in “Human Cell”

MicroRNAs may help diagnose and treat hair loss disorders.

Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

research Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

30 citations , July 2019 in “PloS one”

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

research Regulatory T-Cells in Alopecia Areata

21 citations , April 2019 in “Journal of cutaneous pathology”

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

research Identification of Blood MicroRNA Alterations in Patients With Severe Active Alopecia Areata

15 citations , April 2019 in “Journal of Cellular Biochemistry”

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

research Study of Skin Expression of MicroRNA-146a in Patients with Alopecia Areata

July 2018 in “Benha Journal of Applied Sciences”

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

research An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

130 citations , February 2018 in “Journal of Investigative Dermatology”

Tofacitinib may help treat severe hair loss, but more research is needed.

research Identification of Differentially Expressed miRNAs in Alopecia Areata That Target Immune-Regulatory Pathways

14 citations , March 2017 in “Genes and immunity”

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

research The Role of Lymphocytes in the Development and Treatment of Alopecia Areata

60 citations , September 2015 in “Expert Review of Clinical Immunology”

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

research The Autoimmune Basis of Alopecia Areata: A Comprehensive Review

162 citations , October 2014 in “Autoimmunity reviews”

Alopecia areata is caused by the immune system attacking hair follicles.

Transcriptional Profiling in Alopecia Areata Defines Immune and Cell Cycle Control Related Genes Within Disease-Specific Signatures

research Transcriptional Profiling in Alopecia Areata Defines Immune and Cell Cycle Control Related Genes Within Disease-Specific Signatures

61 citations , September 2010 in “Genomics”

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

research Alopecia Areata in Korea (1982–1994)

46 citations , November 1995 in “The Journal of Dermatology”

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.